- Home
- ISOU vs PACB Comparison
ISOU vs PACB Comparison
Compare ISOU & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISOU
- PACB
- Stock Information
- Founded
- ISOU 2016
- PACB 2000
- Country
- ISOU Canada
- PACB United States
- Employees
- ISOU N/A
- PACB N/A
- Industry
- ISOU
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- ISOU
- PACB Industrials
- Exchange
- ISOU Nasdaq
- PACB Nasdaq
- Market Cap
- ISOU 391.8M
- PACB 369.5M
- IPO Year
- ISOU N/A
- PACB 2010
- Fundamental
- Price
- ISOU $10.00
- PACB $1.49
- Analyst Decision
- ISOU
- PACB Buy
- Analyst Count
- ISOU 0
- PACB 7
- Target Price
- ISOU N/A
- PACB $1.90
- AVG Volume (30 Days)
- ISOU 74.1K
- PACB 6.5M
- Earning Date
- ISOU 08-01-2025
- PACB 11-06-2025
- Dividend Yield
- ISOU N/A
- PACB N/A
- EPS Growth
- ISOU N/A
- PACB N/A
- EPS
- ISOU N/A
- PACB N/A
- Revenue
- ISOU N/A
- PACB $156,110,000.00
- Revenue This Year
- ISOU N/A
- PACB $6.15
- Revenue Next Year
- ISOU N/A
- PACB $15.68
- P/E Ratio
- ISOU N/A
- PACB N/A
- Revenue Growth
- ISOU N/A
- PACB N/A
- 52 Week Low
- ISOU $5.72
- PACB $0.85
- 52 Week High
- ISOU $10.50
- PACB $2.72
- Technical
- Relative Strength Index (RSI)
- ISOU 62.03
- PACB 67.53
- Support Level
- ISOU $9.71
- PACB $1.19
- Resistance Level
- ISOU $10.37
- PACB $1.34
- Average True Range (ATR)
- ISOU 0.62
- PACB 0.08
- MACD
- ISOU -0.01
- PACB 0.03
- Stochastic Oscillator
- ISOU 74.44
- PACB 88.89
About ISOU IsoEnergy Ltd. Common Shares
IsoEnergy Ltd is engaged in the acquisition, exploration, and evaluation of uranium properties in Canada. The company's project profile includes Thorburn Lake, Radio, Geiger, and Larocque East. and others. It operates in Canada, the United States, and Australia.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.